0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Kits > IFN-gamma > CRS-A017

ClinMax™ Human Interferon-γ (IFN-γ) ELISA Kit

For research use only.

Order Now

    Product Details
    ClinMax™ Human Interferon-γ(IFN-γ) ELISA Kit is a ready-to-use immunoassay kit, specifically designed to quantitate natural and recombinant human IFN-gamma that is present in biological samples, such as human serum, plasma, and cell culture supernatants. Our ClinMax™ ELISA Kit provides several benefits:
    1. Standards to calibrate with NIBSC/WHO standards for comparable results.
    2. Fully validation in biologic samples for detection range, sensitivity, inter- and intra-plate CV, recovery, dilution linearity, specificity, and matrix effects to ensure reliable results according to ICH M10 guideline.
    3. High-quality antibody pairs and protein standards, along with rigorous quality control, to guarantee consistent results across different batches.
    4. Simplified and straightforward protocols and ready-to-use reagents to save assay time.
  • Application

    The kit is developed for quantitative detection of natural and recombinant human IFN-gamma in serum, plasma and cell culture supernatants.

    It is suitable for potency assay of CAR-T/NK cell therapy.

    It is for research use only.

  • Workflow
     IFN-gamma Workflow
    Key Features
    AnalyteIFN-γ
    Assay TypeSandwich-ELISA
    ReactivityHuman
    Sensitivity5.309 pg/mL
    Range19.5 pg/mL-1250 pg/mL
    Assay Time2 hr 50 min
    Sample TypeCell Culture Supernatants, Plasma, Serum.
    Sample volume100 μL
    Format96-wells plate breakable into 12 x 8 wells strips

    Elevate your research experience with our Cytokine/Biomarker Detection Kits, where accuracy, reliability, and ease of use are converging to deliver exceptional results.

  • Storage
    Keep the unopened kit stored at 2-8 °C. Avoid using the kit beyond its expiration date. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Typical Data Please refer to DS document for the assay protocol.
 IFN-gamma TYPICAL DATA

For each experiment, a standard curve needs to be set for each microplate, and the specific OD value may vary depending on different laboratories, testers, or equipment. The following example data is for reference only. The sample concentration was calculated based on the results of the standard curve. The minimum detectable concentration of IFN-γ is less than 5.309 pg/mL.

Validation
Sample Values

Cell Culture Supernatant – Human peripheral blood mononuclear cells (PBMCs) were cultured and stimulated using anti-CD3&CD28 magnetic beads and several concentrations of lipopolysaccharide (LPS) then detected IFN-γ secretion amount on Day 3 (72 hours).

 IFN-gamma SAMPLE VALUES
Dilution Linearity

High concentrations of human IFN-γ were added to different diluted substrates for gradient dilution to evaluate the linearity of the assay.

 IFN-gamma DILUTION LINEARITY
Intra-Assay Statistics

20 replicates of each of 3 samples containing different IFN-γ concentrations were tested in one assay. Acceptable criteria: CV<10%.

 IFN-gamma INTRA-ASSAY STATISTICS
Inter-Assay Statistics

3 samples containing different concentrations of IFN-γ were tested in independent assays. Acceptable criteria: CV<10%.

 IFN-gamma INTER-ASSAY STATISTICS
Recovery

IFN-γ was spiked into 3 human serum samples, and then analyzed. The average recovery of IFN-γ for serum samples is 93.5%, range is 85.2% - 105.2%.

 IFN-gamma RECOVERY
Materials Provided
IDComponentsSize
CRS017-C01Pre-coated Anti-IFN-γ Antibody Microplate1 plate
CRS017-C02Human IFN-γ Standard30 μg
CRS017-C03Biotin-Anti-IFN-γ Antibody25 μg
CRS017-C04Streptavidin-HRP50 μL
CRS017-C0510xWashing Buffer 50 mL
CRS017-C062xDilution Buffer50 mL
CRS017-C07Substrate Solution12 mL
CRS017-C08Stop Solution7 mL
  • Clinical and Translational Updates

Comments (0)


ETA des produits en stock: 2 jours ouvrables

Price(EUR) : €500.00

Price(EUR) :


Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:3 Details
  • Number of Drugs in Clinical Trials:9 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop

Laisser un message